Circulating Cell-Free DNA in Renal Cell Carcinoma: The New Era of Precision Medicine

SIMPLE SUMMARY: Early diagnosis of renal cell carcinoma (RCC) is challenging and typically incidental. Currently, several therapeutic strategies are used for the treatment; however, no established predictive biomarker has been established yet, and the optimal treatment choice and sequence of use rem...

Descripción completa

Detalles Bibliográficos
Autores principales: Francini, Edoardo, Fanelli, Giuseppe Nicolò, Pederzoli, Filippo, Spisak, Sandor, Minonne, Erika, Raffo, Massimiliano, Pakula, Hubert, Tisza, Viktoria, Scatena, Cristian, Naccarato, Antonio Giuseppe, Loda, Massimo, Nuzzo, Pier Vitale
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497114/
https://www.ncbi.nlm.nih.gov/pubmed/36139519
http://dx.doi.org/10.3390/cancers14184359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497114/
https://www.ncbi.nlm.nih.gov/pubmed/36139519
http://dx.doi.org/10.3390/cancers14184359

Ejemplares similares